Briefly noted: P Singh et al. Clin Gastroenterol Hepatol 2018; 16: 823-36. After a systemic review which selected 96 articles from a pool of 3843 published between 1991 through 2016, the authors determined a pooled global prevalence of 1.4% in 275,818 individuals based on seroprevalence (positive TTG or EMA). Biopsy-confirmed celiac disease was noted in 0.7% in 138,792 individuals.
In their study, biopsy-proven disease was most prevalent in Argentina, Egypt, Hungary, Finland, Sweden, New Zealand, and India.
Related blog posts:
- Never Too Old for Celiac Disease
- Northern Latitudes -Higher Prevalence of Celiac Disease and Gluten Avoidance
- Celiac Disease Epidemic (High rate of celiac disease reported in Denver children)
- Vaccine for Celiac Disease
- Celiac Disease Risk –TEDDY study
- Celiac Disease and Mode of Delivery -Perhaps Not Very Consequential
- Celiac disease and diabetes
- Celiac disease and psychological problems
- How Birth Can Affect Your GI Tract | gutsandgrowth
- How to Protect Children From Celiac Disease
- Why are we seeing so many more cases | gutsandgrowth
- Why is Celiac Disease Becoming More Prevalent?
Pingback: First Year of Life Antibiotics and Celiac Disease | gutsandgrowth